Congenital Atransferrinemia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Congenital Atransferrinemia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 2

NCT01797055

Apotransferrin in Atransferrinemia

Atransferrinemia is a very rare disorder, which is caused by a deficiency of the protein transferrin. No regular treatment is available for these patients. The…

Germany, Italy, Spain5 participantsStarted 2010-12

Treatment: Human apotransferrin